By Nicholas Thomas · Wednesday, September 9, 2026 · filed 5:25 PM ET — TrendyVest. Not investment advice. TrendyVest and its writers may own securities discussed here.
Every close below carries its source. Under the rule this desk adopted last night, a close is sworn in when two feeds carry the same number — some of tonight's are, and I say which.** --- **THREE CORRECTIONS, IN THE SAME FONT AS THE MISTAKES.** *One — the buyback.* The Treasury's enlarged long-end buyback did not happen today. I wrote in last night's Closing Edge that Wednesday was "the first day of the Treasury's doubled buybacks," repeated it in this morning's Premarket Edge, and wrote at midday that "today is the first operation." Wrong three times.
What happened today was the announcement: at 11:16 the Treasury said Thursday's operation would be up to $6 billion, and it runs tomorrow between 1:40 and 2:00, buying 10-year notes and 20-year bonds that mature between February 2037 and August 2046, per Fox Business's account of the release and Yahoo Finance's timing. The Treasury's own tentative schedule reads the same way — announced 9/9, executed 9/10. The operation that did run today was a different bucket entirely, the short-end one for paper inside two years, capped at $12.5 billion.
I read "beginning September 9" in the August 19 release as an operation date. It was an announcement date. *Two — the spread.* At midday I told you the Brent–WTI spread had "closed $1.72 since dawn" and put a row on it. The number under that sentence was Trading Economics' Brent at $100.26 beside its WTI at $96.41.
Every other feed this desk can reach had Brent a dollar higher at the same hour — Investrade's mid-morning stamp was $101.26, the Reuters open print was $100.69 — which means the two Trading Economics quotes weren't from the same minute, and the spread I printed was a stale Brent sitting next to a live WTI. At the settlements the spread is **$5.16** — Brent $101.21, WTI $96.05, per Investrade — wider than the $4.93 at the open, not narrower. The story was wrong, the row loses, and the rule gets a clause: every oil level printed beside its companion benchmark, *from the same feed at the same minute.* That's the amendment. *Three — UnitedHealth.* At 1:30 I wrote that UnitedHealth was down 5 percent with "no headline." There was a headline, and it was out before the open.
The company's executives were at the Wells Fargo conference reaffirming 2026 guidance early enough that Investing.com's transcript summary is stamped 8:50 a.m., and Bloomberg's report that TPG is buying into WellMed's Florida clinics was on the wire by 10:40, per 24/7 Wall St. The five-reasons list I quoted was the sell side's morning note, which mentioned neither. I didn't find the news; that's not the same as the news not existing, and I printed it as if it were.
More on what the stock did with it below. **THE CLOSE.** The AP's wrap, matched to the penny by a second feed (VistaP Global's close table) on the three big indexes, which under last night's rule means they're sworn tonight: **S&P 500 7,636.36, down 37.16, or 0.5 percent. Dow 52,380.66, down 405.41, or 0.8 percent. Nasdaq 26,253.34, down 168.07, or 0.6 percent.** The Russell 2000 is not sworn: the AP has 2,921.23, down 38.97; VistaP has 2,921.72; Investrade rounds to 2,921.
Last night the Dow fell by four different numbers. Tonight it's the small caps that have three, and I'll take the trade. Breadth was 16 decliners for every 7 advancers, per Investrade, and only two of eleven sectors rose.
Tuesday's closes, for the record, are now sworn in: the AP's 7,673.52 / 52,786.07 / 26,421.41 appeared on Schwab's morning note to the penny. The 10-year finished at 4.83 percent — Trading Economics 4.83, Investrade 4.832, ZeroHedge 4.837, up three to four basis points — the highest close since November 2023 by Investrade's count. The 30-year was near 5.3, above it by AOL's account. **WTI settled at $96.05, up $3.02; Brent at $101.21, up $3.29**, per Investrade — and the Brent number is on a second feed, a Reforma wire headline reading "Brent cierra en 101.21 dólares," so Brent is sworn and WTI isn't yet.
One feed, FXStreet, carried a WTI "just above $94" this afternoon that matches nothing else on the tape; it's disclosed and unused. December gold settled at $4,460.70, up $21.70. The yen was 153.63, five percent stronger than a year ago and at its firmest since February.
Reuters' explainer on why $100 isn't $120 is the best thing written on oil today: Oman futures at $121.68, spot Dubai and Oman more than $20 over November cargoes, Vitol's Russell Hardy counting about 9 million barrels a day of Gulf crude exports against roughly 20 million before the war, Rystad's demand destruction at 3.5 million barrels a day this quarter, and Argus's David Fyfe: "physically things are incredibly tight" and "the diesel market is screaming shortage." As for when Brent was last above $100: Reuters says late July, Cornerstone Futures says July 24, AOL says mid-July, Trading Economics says May. The desk goes with Reuters. **FINANCIALS — THE BOND MARKET GRADED BESSENT TWICE.** This is the day's story, so it goes first. At 11:16 the Treasury announced tomorrow's buyback at $6 billion: triple the $2 billion standard, half again more than the "at least $4 billion" it promised on August 19.
The market sold it. Bloomberg had the 10-year up about six basis points to 4.85 within minutes, and the reason was on the record before the number was — BNP Paribas' Guneet Dhingra had said it would take a $7 billion maximum to surprise anyone, and anything less would get sold. Investrade's version: $6 billion was "only about half" what investors expected.
Strive's Matt Cole told Fox Business the "market's calling a bluff because these are very small sizes." Evercore's Krishna Guha: "Scott has absolutely adopted a very activist model as Treasury secretary." A man who said "I am the house now" on Tuesday put $6 billion on the table on Wednesday, and the table asked for more. Then, at 1:00, the market graded him again and this time gave him an A. The $39 billion 10-year reopening came at **4.834 percent against a 4.849 when-issued — a 1.5 basis point stop-through, the largest since April 2025**, per InvestingLive and ZeroHedge.
Bid-to-cover 2.71, the highest since April 2016. Indirect bidders — the foreign-and-fund category — took **79.18 percent**. Primary dealers were left holding **4.31 percent**, the smallest share since late September 2025.
And 4.834 percent is the most the United States has paid to borrow for ten years at auction since August 2007. Hold both facts at once, because they're one fact. The Midday's thesis was that dealers' balance sheets are full of AI paper on the day the Treasury sells 10-years.
The auction didn't refute that; it priced it. Dealers took 4 percent because at 4.83 everyone else wanted the bonds, and the concession *was* the demand. That's the uncomfortable read on tomorrow's operation, too: holders will sell the Treasury its 10-to-20-year paper at these levels gladly, which is exactly why $6 billion doesn't move the yield.
Last night's row — *Wednesday's H.15 at or below Tuesday's 4.78* — is losing by five basis points on every feed. The Fed's table grades it tomorrow afternoon. Two more financial prints.
Amazon's sterling debut raised **£4.25 billion, $5.76 billion**, per Reuters' Yoruk Bahceli and a Yahoo carry citing Bloomberg: £1.25 billion of 3-year at about 5.2 percent, £1 billion each of 6-, 12- and 19-year, the 19-year at about **6.7 percent**, on a book that peaked near £12 billion and finished above £10.65 billion after pricing tightened. The duration test Bloomberg Intelligence described this morning was passed, at a price — Amazon is paying more for nineteen-year sterling than Oracle pays for ten-year dollars — and TwentyFour's Gordon Shannon put the asterisk on it: "It does show that demand is not unlimited." Amazon's bond sales this year are about $100 billion including today, per Yahoo's account; the $92 billion this desk carried this morning was the pre-deal figure. And Chime is buying Stride Bank for $590 million in cash, closing in the first half of 2027, to be renamed Chime Bank — a fintech buying its own charter.
Chime was up about 5 percent at mid-morning and raised its quarter. The Bancorp, Chime's other sponsor bank, fell **20.9 percent to $50.73 by 3:12**, per the Fool; Investrade put the revenue at risk at 8 to 14 percent, and KBW's point was the simpler one: once Chime owns a bank, it can move its products in-house. The sponsor-bank model — rent a charter, keep the customer — just watched its best customer stop renting.
XLF was $57.16 at 3:19, down 0.24 percent, on a day's range of $56.73 to $57.33; the close hadn't reached a feed this desk trusts by press time, and the row it settles doesn't need it. See the book. **TECH — APPLE PICKED THE FALSIFIER TO THE DOLLAR.** The prices, from Apple's newsroom: **iPhone 18 Pro $1,199 and Pro Max $1,299**, 256 gigabytes base, pre-orders Saturday at 5 a.m. Pacific, in stores September 18. **iPhone Duo — the foldable — $1,999** at 256 gigabytes and $3,199 at two terabytes per MacRumors, pre-orders October 16, on sale October 23 in more than 70 countries.
A20 Pro on a 2-nanometer process; Apple's own C2 modem in both; a 7.6-inch inner display and Touch ID on the side button of the Duo rather than Face ID. John Ternus, in the release: "iPhone Duo is the most transformational change to iPhone since the original." Trade-in credit up to $885, carrier credits up to $1,200 — the price rose $100 and the subsidy rose with it, which is how Apple raises prices without raising them. The rows.
Lily's Sunday row — *60% the 18 Pro starts at or above $1,199* — is a **WIN**, on the newsroom and MacObserver's table. Mine — *60% the foldable starts at or above $2,099* — is a **LOSS**, and the falsifier I wrote this morning, "a $1,999 price to buy the category," is the number Apple chose. Here's what I got wrong: I read three price expectations as a floor when they were a ceiling, and I underweighted the other half of the June precedent.
Apple took its memory-cost increases on Macs and iPads in June; it had no reason to spend the foldable's launch on margin. The stock's row went the other way. Apple closed **$315.34, down 0.28 percent**, on stockanalysis and Yahoo — 88 cents under Tuesday's $316.22, after a range of $309.90 to $319.15, down 2 percent at the low and up 0.9 at the high. *60% Apple closes below $316.22* is a **WIN by 88 cents**, two feeds, sworn.
Benzinga's pre-event note had KeyBanc at Underweight, $250, on 80 million iPhone 18 builds against 91 million a year ago, and BofA at Buy, $380. The June selloff did not repeat. The June price hike did. *Meta closed $653.69, up 6.55 percent*, the biggest gainer among the megacaps, per stockanalysis — Muse, and a line from Meta's chief AI officer, carried by Investrade, that users are engaging "10x more than testing cohorts." Alphabet fell 2.28 percent to $330.65 and Amazon 1.78 to $252.40, and Mizuho is already drawing the line from a personal agent to Booking and Expedia.
Lily's morning number sits under all of it: $784 million of free cash flow last quarter. *Marvell rose 4.7 percent to $236.06* by 4:03, per the Fool, after Matt Murphy told Cramer on Tuesday night — hours after Qualcomm took the Amazon inference-chip deal this desk covered that morning — that "we are basically the Switzerland of this entire market right now. We work with everybody." Twelve billion of revenue this year and eighteen next, more than fifteen of it data center, is the claim. *Micron closed $1,027.77, up 2.75 percent*, stockanalysis and Google Finance agreeing to the penny, off a low of $992.29 (Yahoo: $992.30). *Intel closed $106.24, up 1.69 percent*, per stockanalysis, on a range of $102.70 to $106.69; the row that expected a morning-after fine is a loss, graded below. Analog Devices is paying $1.35 billion for Alif Semiconductor, an edge-AI processor company.
Dell traded to an all-time high at mid-morning on an Evercore note mapping a path to $1,000. ServiceTitan was down 31 percent and Braze 16 by mid-morning for beats that were merely thin, which is what software gets paid this month. Oracle closed **$161.63, down 0.55 percent**, into tomorrow night's print, with the options market pricing an 11 percent move.
And SpaceX, on the day its 319 million shares came unlocked, fell **3.86 percent to $147.55 on 114.6 million shares** — JPMorgan's $15.5 billion of passive index buying is real, but it arrives by September 21, not on unlock day, and today the sellers came first. **INDUSTRIALS — THE BACKLOG, THE DOWNGRADE, AND A CHEMICALS MAJOR EYEING THE EXIT.** AeroVironment reported after the bell: revenue $480.5 million, up 6 percent, a first-quarter record; adjusted EPS **$0.59 against $0.30 consensus**, per Investing.com; **funded backlog $1.5 billion, up 37 percent**; bookings $0.7 billion, book-to-bill 1.4. Wahid Nawabi called it "landmark strategic wins." The stock had closed **$140.80, down 5.36 percent** — 24/7 Wall St. had the drone group "bleeding out on a day with zero company-specific news," AeroVironment down 41 percent on the year by its count — and was $145.00, up 2.98 percent, at 5:07 after hours, having been up more than 4 at 4:14. What I'd flag: full-year guidance is unchanged, $2.125 to $2.225 billion of revenue and $3.02 to $3.34 of EPS, and both midpoints sit under consensus ($2.19 billion, $3.22).
A quarter this strong with a year this unchanged is a company telling you the second half was already counted. The war is on the tape; the drones are in the backlog; the stock is down 41 percent anyway. The other industrial story is the 10-year at 4.83 reaching the aggregates.
Wells Fargo cut Eagle Materials and Amrize to Equal Weight and Vulcan to Underweight, citing "an increasingly cautious 2027 outlook due to leaner government spending and higher rates," and upgraded Martin Marietta on acquisition benefits, per Investrade. Rock, cement and roads are a rates trade, and someone finally priced it. Dow is weighing an exit from Sadara, its $20 billion chemicals venture with Aramco in Jubail, in which it holds 35 percent, per Bloomberg via Reuters — a chemicals major considering leaving the Gulf during a Gulf war; the stock swung from $28.96 to $30.20 and was $29.61 at 3:25.
Booking lost its last appeal on the €1.63 billion ETraveli deal at the EU General Court, which endorsed the Commission's "reverse leveraging" theory — an ecosystem as the harm — and was down 4 percent at 10:00. The EIA's monthly outlook, out today, forecasts record U.S. electricity generation of 4,368 billion kilowatt-hours in 2026, up 2.2 percent, and another 1.7 percent in 2027, on "data center development"; it also has Brent averaging about $90 in the second half of this year and $74 next year. The tape's answer to the first forecast was to sell utilities 1.15 percent.
Its answer to the second was $101.21. Energy was the trade that worked: Occidental, APA, Conoco, Chevron and Exxon were among the S&P's best, per Investrade. **BIOTECH — THE FDA GOT PERMANENT LEADERS, AND THE TAPE SHRUGGED.** HHS on Tuesday made the acting heads permanent: **Michael Davis at CDER, Karim Mikhail at CBER**, Bret Koplow at tobacco, and Jared Seehafer as the agency's first Deputy Commissioner for Technology and Artificial Intelligence. BioPharma Dive's count is the context: CDER had five leaders in a year, Vinay Prasad joined and left CBER twice, and Marty Makary resigned as commissioner in May after "mass layoffs and erratic decision-making that troubled drugmakers and investors." RBC's Brian Abrahams: the appointments are "likely to be seen as a sign of continuity and stability that should help ease concerns that the FDA will see major shifts in policy." The sector's response was XBI at $160.01, down 1.19 percent at 2:47.
Continuity is worth more than a day, but it isn't worth a day with the 10-year at 4.83. The single-stock prints were the usual binaries. Tyra fell about 22 percent, per RTTNews — 26 at the mid-morning low, per Investrade — after dabogratinib showed a 57 percent three-month complete response in bladder cancer against the 70 percent the company itself had set as the bar at a BofA conference; six of eight single-lesion patients responded, which is the subgroup TD Cowen's Tyler Van Buren calls the closest analog to the planned Phase 3.
Evommune was down 15 after EVO756 missed its primary endpoint. Barclays took Sagimet to $18 from $8 on defanistat for acne; Jefferies took Summit to Buy, $25, ahead of second-half survival data. And UBS initiated the life-science tools group — Danaher, Thermo, Illumina, Natera, Waters, West and others at Buy, GRAIL at Buy — with an end market it calls "GDP plus 2." That's the least exciting sentence in this column and possibly the most durable. **HEALTHCARE — ONE STOCK SOLD ON NEWS IT HAD, ONE SOLD ON NEWS IT GOT.** UnitedHealth first.
The sequence, properly ordered: before the open, at the Wells Fargo conference, management reaffirmed 2026 and put numbers on it — Medicare Advantage margins tracking to the upper half of the 2-to-4 percent target, commercial margins flat year over year, Optum Health's turnaround "ahead of schedule," 2026 framed as the trough and 2027 as the recovery, per Investing.com's transcript summary. Bloomberg reported TPG is buying into WellMed's Florida senior-care clinics inside Optum Health; CFO Wayne DeVeydt, per 24/7 Wall St.: "We didn't need the dollars, we have the dollars to invest, but we needed the focus and somebody that could actually work with us locally." The stock opened near $405, was sold to **$378.08, down 5.7 percent**, and closed **$393.06, down 1.94 percent** — a $28 range and a 4 percent bounce off the low, per stockanalysis. So the tape sold a reaffirmation and a partial clinic sale as if they were a warning, and then, over four hours, decided they weren't.
I wrote at midday that a stock sold on nothing and bought back is one story and a stock sold on nothing that stays down is a story someone else knows. It came back. Positioning, confirmed; and the "nothing" was my miss, not the market's.
Cooper is the other story, and it's the bigger one. The stock fell **6.08 percent to $63.58** during the session, ahead of the print, per stockanalysis. Then the print: revenue $1.066 billion, up 1 percent, CooperVision flat, non-GAAP EPS $1.15 against $1.12 consensus — and fourth-quarter guidance of **$1.05 to $1.09 against $1.19**, a full year of $4.51 to $4.55 against $4.63, per Investing.com.
The board also ended its strategic review by keeping CooperSurgical, on the grounds that "offers received were not in shareholders' best interest," and raised the buyback authorization to $3 billion from $2. The stock was **down 15.3 percent to $53.80 after hours** at 4:35, per Investing.com. Read the GAAP line carefully: $2.24 of EPS against $0.49 a year ago is "a favorable completion of a significant tax matter," in Al White's words, not the business.
The business is a contact-lens maker cutting U.S. channel inventory and a surgical unit facing a new competitor in non-hormonal IUDs and a fertility litigation settlement. A company that shops a division, doesn't like the bids, keeps it, and guides down in the same release has told you what the bids were. **THE SMALLER PRINTS.** American Eagle's beat is a tariff refund: gross margin up 980 basis points, of which 1,300 came from $196 million of refunds received and 330 went the other way as merchandise-margin deleverage; comps up 6, Aerie up 19, the namesake brand down 1. Casey's was down 16 percent at mid-morning on a same-store number six-tenths light; Signet was up 19 on a raised year, both per Investrade.
Fox's $22 billion Roku deal got a DOJ second request over Tubi and self-preferencing. The stockanalysis "previous close" fields moved again overnight — Broadcom to $368.56 from the $368.36 this desk carried, Tesla to $368.16 from $368.22 — which is the whole reason the swearing-in rule exists; Broadcom closed $364.38, down 1.13 percent, Tesla $367.81, down 0.10. **THE BOOK AT THE CLOSE.** Graded tonight on two feeds where I have them, and I say where I don't. *Lily — Kospi above 7,000 by Friday:* **WIN**, settled this morning. *Lily — 18 Pro at or above $1,199:* **WIN**, Apple newsroom and MacObserver. *Mine — foldable at or above $2,099:* **LOSS**, Apple newsroom and MacRumors, at the falsifier's exact number. *Mine — Apple closes below $316.22:* **WIN**, $315.34 on stockanalysis and Yahoo. *Mine — Micron trades below $1,000 intraday:* **WIN**, low $992.29 / $992.30 on two feeds. *Mine — Micron closes above $1,000:* **WIN**, $1,027.77 on stockanalysis and Google Finance. *Mine — Intel closes below $104.47:* **LOSS**, $106.24 on stockanalysis; one clean feed, but no feed had it under $105 after 3:00, and I said last night I'd print it in the same size if it lost. The crowd is paying for the machine while it waits for the customer. *Mine — Brent's Wednesday settlement below $100:* **LOSS**, $101.21 on Investrade and the Reforma wire. *Lily — Brent settles at or above $100 at least once by Friday:* **WIN**, same two feeds. *Mine — Brent–WTI settlement spread under $4.50:* **LOSS** — $5.16 on Investrade's pair, and above $4.50 on any WTI print any feed carried today; the correction is at the top. *Episode 28 — financials outperform utilities over five sessions from September 2's 9:33 stamps:* **LOSS**.
XLU is up 1.87 percent from $42.16 to tonight's $42.95, and XLF is down 0.56 from $57.48 to the 3:19 stamp; every price in XLF's range today sits below the stamp, so the close can't change the grade. The steepener was supposed to pay the banks. It paid the megawatts. *Mine — Wednesday's H.15 at or below Tuesday's:* losing by five basis points; the Fed's table decides Thursday. *Standing:* Lily's *10-year at or above 4.80 on Friday's H.15* leads at 4.83.
Yesterday's *utilities beat financials this week* leads — from the September 4 closes, XLU is down 0.3 percent and XLF about 1.6. *Micron above $1,000 on Friday* has $27.77 of room. *Broadcom above $357.71 on Friday* is $6.67 in the money, or $6.48 against the revised $357.90 if that's what two feeds say. *Tesla below $376.37 on Friday* has 2.3 percent of room. Intel's Friday and September 30 rows are about $6 in the money. Episode 33's *ECB hikes* row grades at 8:15 tomorrow and has become the easiest call on the book — all 65 economists in Reuters' poll expect 25 basis points to 2.50 percent, and the market has it fully priced.
Lily's eight Oracle rows grade tomorrow night. **TOMORROW, HOUR BY HOUR.** 8:15, the ECB — 25 to 2.50 expected; the question is whether Lagarde calls it a sweet spot or a start, with markets pricing about 47 basis points more by year-end and 80 by next June, per InvestingLive. 8:30, August PPI — consensus 0.4 percent headline and 5.3 year over year, 0.3 and 4.6 core, per Investrade, against 0.0 and 4.7 in July — and jobless claims, 206,000 consensus. 10:30, the EIA report for the week ending September 4 — Thursday, not Wednesday, as corrected at midday; the last one was a 4.45 million barrel draw. 1:00, the 30-year auction, into a long end the 10-year just cleared at 2007 yields. 1:40 to 2:00, the $6 billion buyback — the actual operation, this time. After the close: Oracle, consensus about $19.14 billion and $1.74 against a guide of $1.72 to $1.76, with $638 billion of RPO to update; Adobe, consensus $6.08 or $6.09 depending on the feed. Around 4:15, the H.15 with Wednesday's 10-year, and a row settles.
Friday: CPI at 8:30, consensus 3.4 percent headline, core 2.4 to 2.5 depending on the feed; Michigan sentiment, 51.7; Kroger; settlement day for the Friday book. Saturday at 8 a.m. Eastern, iPhone 18 Pro pre-orders open.
Monday the 14th, UnitedHealth goes ex-dividend. The Fed says nothing until the 16th. Duo pre-orders October 16. **THE ROWS.** *Row one — 65% that Brent's Thursday ICE settlement is at or above $100 again.* The premium became a level, and a level doesn't give back its first day on the far side of